Trial Profile

The Impact of Prothrombin Complex Concentrate on the Anticoagulatory Effects of Edoxaban

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 14 Oct 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Edoxaban (Primary) ; Prothrombin complex concentrate
Indications Embolism; Stroke; Venous thromboembolism
Focus Pharmacodynamics
Sponsors Daiichi Sankyo Company

Most Recent Events

16 Aug 2016 Results of this and two other studies published in the British Journal of Clinical Pharmacology.
15 Apr 2014 New trial record
29 Mar 2014 Results presented at the 63rd Annual Scientific Session of the American College of Cardiology.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com